Maravai LifeSciences Holdings, Inc. (MRVI) Net margin 2019–2025
Maravai LifeSciences Holdings, Inc. (MRVI) net profit margin by fiscal year — reported net income divided by reported revenue.
-70.4%FY2025 · since FY2019: -3.1% → -70.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -70.4% | -14.5 pp |
| FY2024 | -55.9% | -14.7 pp |
| FY2023 | -41.2% | -66.1 pp |
| FY2022 | 24.9% | +2.2 pp |
| FY2021 | 22.8% | -8.5 pp |
| FY2020 | 31.3% | +34.4 pp |
| FY2019 | -3.1% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice